HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Healing of articular cartilage defects treated with a novel drug-releasing rod-type implant after microfracture surgery.

Abstract
Microfracture therapy is a widely used technique for the repair of articular cartilage defects because it can be readily performed arthroscopically. However, the regenerated cartilage after microfracture surgery clearly differs from normal articular cartilage. This suggests that the clinical outcome of patients undergoing microfracture therapy could be improved. Dehydroepiandrosterone sulfate (DHEA-S) is known to protect against articular cartilage loss. Therefore, in an effort to achieve cartilage regeneration of high efficacy, we manufactured a DHEA-S-releasing rod-type implant for implantation into the holes produced by microfracture surgery. The polymeric rod-type implant was made of biodegradable poly (D, L-lactide-co-glycolide) (PLGA) and beta-tricalcium phosphate to enable controlled release of DHEA-S. The implant was dip-coated with a dilute PLGA solution to prevent the burst release of DHEA-S. The rod-type implant was sufficiently stiff to permit implantation into the holes made by microfracture. DHEA-S was released from the implant for more than four weeks. Furthermore, eight weeks after implantation into rabbit knees, the implants dramatically enhanced cartilage regeneration compared to control. Moreover, the degradation of the implant over the eight weeks from implantation into the knee did not induce any adverse effects. Therefore, this polymeric rod-type implant does not only provide an improvement in microfracture surgery, but also has great potential as a new formulation for drug delivery.
AuthorsIn Kyong Shim, Yeo Joo Yook, Sang Young Lee, Sang Hoon Lee, Ki Dong Park, Myung Chul Lee, Seung Jin Lee
JournalJournal of controlled release : official journal of the Controlled Release Society (J Control Release) Vol. 129 Issue 3 Pg. 187-91 (Aug 07 2008) ISSN: 1873-4995 [Electronic] Netherlands
PMID18547670 (Publication Type: Evaluation Study, Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Buffers
  • Calcium Phosphates
  • Coloring Agents
  • Drug Implants
  • Phenazines
  • Phosphates
  • Powders
  • Solvents
  • beta-tricalcium phosphate
  • Polylactic Acid-Polyglycolic Acid Copolymer
  • Polyglycolic Acid
  • Lactic Acid
  • Dehydroepiandrosterone Sulfate
  • Methylene Chloride
  • Chloroform
  • safranine T
Topics
  • Animals
  • Arthroplasty, Subchondral
  • Buffers
  • Calcium Phosphates (chemistry)
  • Cartilage, Articular (injuries, pathology, surgery, ultrastructure)
  • Chloroform (chemistry)
  • Coloring Agents (metabolism)
  • Compressive Strength
  • Dehydroepiandrosterone Sulfate (chemistry, metabolism)
  • Drug Implants (chemistry, metabolism, pharmacology)
  • Hydrogen-Ion Concentration
  • Lactic Acid (chemistry)
  • Methylene Chloride (chemistry)
  • Molecular Weight
  • Phenazines (metabolism)
  • Phosphates (chemistry)
  • Polyglycolic Acid (chemistry)
  • Polylactic Acid-Polyglycolic Acid Copolymer
  • Powders
  • Prostheses and Implants
  • Rabbits
  • Solvents (chemistry)
  • Temperature
  • Time Factors
  • Viscosity
  • Wound Healing (drug effects)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: